Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma
Chen‐Tian Shen, Yinan Zhang, Yumin Liu, et al.
Clinical Endocrinology (2017) Vol. 87, Iss. 6, pp. 844-852
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Metabolome analysis for investigating host-gut microbiota interactions
Michael Chen, San‐Yuan Wang, Ching‐Hua Kuo, et al.
Journal of the Formosan Medical Association (2018) Vol. 118, pp. S10-S22
Open Access | Times Cited: 155
Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients
Jing Feng, Fuya Zhao, Jiayu Sun, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 11, pp. 2728-2745
Open Access | Times Cited: 94
Gut microbiota changes and its potential relations with thyroid carcinoma
Xiaqing Yu, Wen Jiang, Russell Oliver Kosik, et al.
Journal of Advanced Research (2021) Vol. 35, pp. 61-70
Open Access | Times Cited: 67
The relationships between the gut microbiota and its metabolites with thyroid diseases
Wen Jiang, Ganghua Lu, Dingwei Gao, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 56
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Alejandro Rubio-Zarapuz, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 221-221
Open Access | Times Cited: 15
Alterations of Gut Microbiome and Metabolite Profiles Associated With Anabatic Lipid Dysmetabolism in Thyroid Cancer
Ganghua Lu, Xiaqing Yu, Wen Jiang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
<p>Oncometabolites as biomarkers in thyroid cancer: a systematic review</p>
Fatemeh Khatami, Moloud Payab, Masoumeh Sarvari, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 1829-1841
Open Access | Times Cited: 54
Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics
Raziyeh Abooshahab, Kourosh Hooshmand, S. Adeleh Razavi, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 46
Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer
Ben Ma, Hongyi Jiang, Duo Wen, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 9, pp. 3713-3725
Open Access | Times Cited: 44
Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma
Cheng Xiang, Haichao Yan
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 24
Interaction of Gut Microbiota with Endocrine Homeostasis and Thyroid Cancer
Qi Liu, Wei Sun, Hao Zhang
Cancers (2022) Vol. 14, Iss. 11, pp. 2656-2656
Open Access | Times Cited: 23
Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC
Genpeng Li, Wenjie Chen, Ke Jiang, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 6, pp. 1601-1617
Closed Access | Times Cited: 13
The Potential of Metabolomics in the Diagnosis of Thyroid Cancer
Margarida Coelho, Luís Raposo, Brian J. Goodfellow, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5272-5272
Open Access | Times Cited: 35
Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry
Jing Zhang, Xinxin Wen, Yuting Li, et al.
Talanta (2021) Vol. 235, pp. 122729-122729
Closed Access | Times Cited: 32
Pleural metastases from differentiated thyroid cancer: clinical features and long-term outcomes
Mengyue Liu, Juan Tang, Nan Sun, et al.
European Thyroid Journal (2025)
Open Access
Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis
Hanfei Zhang, Yuhao Li, Lin Li
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Mechanisms of action of intestinal microorganisms and advances in head and neck tumors
Su Xialu, Ma Faqiang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Emerging Potential of Metabolomics in Thyroid Cancer—A Comprehensive Review
Sonam Kumari, Andrew Makarewicz, Joanna Kłubo-Gwieździńska
Cancers (2025) Vol. 17, Iss. 6, pp. 1017-1017
Open Access
Systems biology approach delineates critical pathways associated with papillary thyroid cancer: a multi-omics data analysis
Febby Payva, K. S. Santhy, Remya James, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders
Hanieh‐Sadat Ejtahed, Pooneh Angoorani, Ahmadreza Soroush, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2019) Vol. 20, Iss. 3, pp. 344-350
Closed Access | Times Cited: 30
Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks
Gizem Gülfidan, Melisa Soylu, Damla Demirel, et al.
Archives of Biochemistry and Biophysics (2021) Vol. 715, pp. 109085-109085
Closed Access | Times Cited: 26
Metabolomics—A Tool to Find Metabolism of Endocrine Cancer
Raziyeh Abooshahab, Hamidreza Ardalani, Maryam Zarkesh, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1154-1154
Open Access | Times Cited: 13
Interactive Association Between Gut Microbiota and Thyroid Cancer
Tianzhichao Hou, Qi Wang, Huajie Dai, et al.
Endocrinology (2023) Vol. 165, Iss. 1
Closed Access | Times Cited: 7
Exploring the potential of myo-inositol in thyroid disease management: focus on thyroid cancer diagnosis and therapy
S. Adeleh Razavi, Mohadeseh Kalari, Tahereh Haghzad, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma
Jiali Qin, Yang Yang, Wei Du, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top